Updated information on COVID-19 and Flu: Restricted visitation is now in effect
Category
Cancer
Sub Category
Breast
Study Name
S1418/BR006: A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK3475 as adjuvant therapy for Triple Receptor-Negative Breast Cancer with less than or equal to 1 cm Residual Invasive Cancer or Positive Lymph Nodes After Neoadjuvant Chemotherapy.
Principal Investigator
Gordan Srkalovic, MD, PhD
Study Information
https://www.clinicaltrials.gov/ct2/show/NCT02954874?term=BR006&rank=1
Contact for Questions
Nurse - Tracy 517-364-2835

Site view: at a glance